Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Drug-Drug Interaction Study of NS-229 with Combined Oral Contraceptive in Healthy Female Subjects
jRCT2071240058Phase 1Completed
- Sponsor
- Nippon Shinyaku
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of NS-229, sponsored by Nippon Shinyaku. Primary endpoints: Plasma concentrations of combined oral contraceptive, Pharmacokinetic parameters of combined oral contraceptive and 2 more. Started Oct 2024; status: completed.
02
Drugs
NS-229
Beyond the preview
Go deeper on jRCT2071240058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071240058.